nodes	percent_of_prediction	percent_of_DWPC	metapath
Pranlukast—ABCC2—Carboplatin—ocular cancer	0.254	1	CbGbCtD
Pranlukast—IL5—epithelium—ocular cancer	0.011	0.221	CbGeAlD
Pranlukast—RNASE3—lymphoid tissue—ocular cancer	0.00933	0.187	CbGeAlD
Pranlukast—IL5—lymphoid tissue—ocular cancer	0.00847	0.17	CbGeAlD
Pranlukast—MUC2—epithelium—ocular cancer	0.00846	0.17	CbGeAlD
Pranlukast—NFKB1—eye—ocular cancer	0.00527	0.106	CbGeAlD
Pranlukast—NFKB1—lymphoid tissue—ocular cancer	0.00371	0.0745	CbGeAlD
Pranlukast—CYSLTR1—lymphoid tissue—ocular cancer	0.00365	0.0731	CbGeAlD
Pranlukast—CYSLTR1—Signaling Pathways—RBL1—ocular cancer	0.000724	0.00104	CbGpPWpGaD
Pranlukast—NFKB1—Neural Crest Differentiation—MYC—ocular cancer	0.000714	0.00103	CbGpPWpGaD
Pranlukast—NFKB1—LPA receptor mediated events—AKT1—ocular cancer	0.000713	0.00102	CbGpPWpGaD
Pranlukast—NFKB1—Leptin signaling pathway—HRAS—ocular cancer	0.000711	0.00102	CbGpPWpGaD
Pranlukast—TNF—TGF-beta Receptor Signaling—HRAS—ocular cancer	0.000705	0.00101	CbGpPWpGaD
Pranlukast—NFKB1—Oncostatin M Signaling Pathway—AKT1—ocular cancer	0.000704	0.00101	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—GNAQ—ocular cancer	0.000701	0.00101	CbGpPWpGaD
Pranlukast—NFKB1—AGE/RAGE pathway—AKT1—ocular cancer	0.000696	0.000999	CbGpPWpGaD
Pranlukast—NFKB1—Glucocorticoid receptor regulatory network—TP53—ocular cancer	0.000693	0.000994	CbGpPWpGaD
Pranlukast—NFKB1—BCR signaling pathway—AKT1—ocular cancer	0.000688	0.000987	CbGpPWpGaD
Pranlukast—NFKB1—Rac1/Pak1/p38/MMP-2 pathway—AKT1—ocular cancer	0.000688	0.000987	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—CCND3—ocular cancer	0.000686	0.000985	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—GNA11—ocular cancer	0.000685	0.000983	CbGpPWpGaD
Pranlukast—TNF—Ceramide signaling pathway—AKT1—ocular cancer	0.000684	0.000982	CbGpPWpGaD
Pranlukast—NFKB1—Downstream signaling events of B Cell Receptor (BCR)—MDM2—ocular cancer	0.000683	0.000981	CbGpPWpGaD
Pranlukast—NFKB1—Apoptosis—TP53—ocular cancer	0.000679	0.000975	CbGpPWpGaD
Pranlukast—NFKB1—Regulation of Telomerase—AKT1—ocular cancer	0.000679	0.000975	CbGpPWpGaD
Pranlukast—NFKB1—Cellular responses to stress—CDK2—ocular cancer	0.000676	0.000971	CbGpPWpGaD
Pranlukast—TNF—Transcriptional regulation of white adipocyte differentiation—TGFB1—ocular cancer	0.000674	0.000968	CbGpPWpGaD
Pranlukast—NFKB1—DNA Damage Response (only ATM dependent)—MYC—ocular cancer	0.000672	0.000964	CbGpPWpGaD
Pranlukast—NFKB1—DNA Damage Response (only ATM dependent)—TGFB1—ocular cancer	0.00067	0.000962	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—CDK2—ocular cancer	0.000667	0.000958	CbGpPWpGaD
Pranlukast—TNF—Angiopoietin receptor Tie2-mediated signaling—AKT1—ocular cancer	0.000662	0.00095	CbGpPWpGaD
Pranlukast—TNF—Allograft Rejection—TGFB1—ocular cancer	0.00066	0.000948	CbGpPWpGaD
Pranlukast—NFKB1—Fc epsilon receptor (FCERI) signaling—MDM2—ocular cancer	0.000652	0.000937	CbGpPWpGaD
Pranlukast—IL5—Platelet activation, signaling and aggregation—AKT1—ocular cancer	0.000651	0.000935	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—MAML2—ocular cancer	0.000646	0.000928	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Breast Cancer Pathway—CCND1—ocular cancer	0.000645	0.000926	CbGpPWpGaD
Pranlukast—NFKB1—Cellular responses to stress—CDK4—ocular cancer	0.000639	0.000917	CbGpPWpGaD
Pranlukast—NFKB1—Apoptosis Modulation and Signaling—TP53—ocular cancer	0.000637	0.000915	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—GNAQ—ocular cancer	0.000637	0.000914	CbGpPWpGaD
Pranlukast—TNF—Apoptosis-related network due to altered Notch3 in ovarian cancer—AKT1—ocular cancer	0.000632	0.000907	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—CDK4—ocular cancer	0.000631	0.000906	CbGpPWpGaD
Pranlukast—TNF—Apoptosis—MYC—ocular cancer	0.00063	0.000905	CbGpPWpGaD
Pranlukast—TNF—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—ocular cancer	0.000629	0.000903	CbGpPWpGaD
Pranlukast—NFKB1—Leptin signaling pathway—AKT1—ocular cancer	0.000628	0.000902	CbGpPWpGaD
Pranlukast—TNF—Folate Metabolism—TP53—ocular cancer	0.000628	0.000901	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—E2F3—ocular cancer	0.000628	0.000901	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—CDKN1B—ocular cancer	0.000628	0.000901	CbGpPWpGaD
Pranlukast—NFKB1—Cellular Senescence—MDM2—ocular cancer	0.000627	0.0009	CbGpPWpGaD
Pranlukast—NFKB1—Downstream signaling events of B Cell Receptor (BCR)—CDKN1B—ocular cancer	0.000624	0.000896	CbGpPWpGaD
Pranlukast—NFKB1—TCR Signaling Pathway—HRAS—ocular cancer	0.000615	0.000883	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	0.000614	0.000881	CbGpPWpGaD
Pranlukast—TNF—Cardiac Hypertrophic Response—AKT1—ocular cancer	0.000613	0.000881	CbGpPWpGaD
Pranlukast—IL5—Cytokine Signaling in Immune system—HRAS—ocular cancer	0.00061	0.000876	CbGpPWpGaD
Pranlukast—NFKB1—TNF alpha Signaling Pathway—HRAS—ocular cancer	0.000604	0.000867	CbGpPWpGaD
Pranlukast—NFKB1—B Cell Activation—MDM2—ocular cancer	0.000604	0.000867	CbGpPWpGaD
Pranlukast—TNF—Downstream signaling in naïve CD8+ T cells—HRAS—ocular cancer	0.0006	0.000862	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—CCND1—ocular cancer	0.000599	0.00086	CbGpPWpGaD
Pranlukast—TNF—Caspase Cascade in Apoptosis—AKT1—ocular cancer	0.000596	0.000856	CbGpPWpGaD
Pranlukast—NFKB1—Fc epsilon receptor (FCERI) signaling—CDKN1B—ocular cancer	0.000596	0.000855	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Breast Cancer Pathway—EP300—ocular cancer	0.000594	0.000853	CbGpPWpGaD
Pranlukast—NFKB1—Glucocorticoid receptor regulatory network—AKT1—ocular cancer	0.000585	0.00084	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—TFDP1—ocular cancer	0.000584	0.000838	CbGpPWpGaD
Pranlukast—NFKB1—B Cell Receptor Signaling Pathway—HRAS—ocular cancer	0.000579	0.000831	CbGpPWpGaD
Pranlukast—NFKB1—SIDS Susceptibility Pathways—EP300—ocular cancer	0.000579	0.000831	CbGpPWpGaD
Pranlukast—NFKB1—Downstream signaling events of B Cell Receptor (BCR)—CDKN1A—ocular cancer	0.000576	0.000827	CbGpPWpGaD
Pranlukast—NFKB1—MicroRNAs in cardiomyocyte hypertrophy—AKT1—ocular cancer	0.000574	0.000824	CbGpPWpGaD
Pranlukast—NFKB1—Apoptosis—AKT1—ocular cancer	0.000574	0.000824	CbGpPWpGaD
Pranlukast—NFKB1—Cellular Senescence—CDKN1B—ocular cancer	0.000572	0.000822	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—GNA11—ocular cancer	0.000564	0.000809	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	0.00056	0.000805	CbGpPWpGaD
Pranlukast—NFKB1—Cellular responses to stress—RB1—ocular cancer	0.000556	0.000798	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—EP300—ocular cancer	0.000555	0.000798	CbGpPWpGaD
Pranlukast—NFKB1—DNA Damage Response (only ATM dependent)—TP53—ocular cancer	0.000552	0.000792	CbGpPWpGaD
Pranlukast—NFKB1—B Cell Activation—CDKN1B—ocular cancer	0.000551	0.000791	CbGpPWpGaD
Pranlukast—NFKB1—Fc epsilon receptor (FCERI) signaling—CDKN1A—ocular cancer	0.00055	0.000789	CbGpPWpGaD
Pranlukast—TNF—Alzheimers Disease—TP53—ocular cancer	0.000544	0.000781	CbGpPWpGaD
Pranlukast—NFKB1—TCR Signaling Pathway—AKT1—ocular cancer	0.000543	0.00078	CbGpPWpGaD
Pranlukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—ocular cancer	0.000541	0.000777	CbGpPWpGaD
Pranlukast—TNF—Adipogenesis—CDKN1A—ocular cancer	0.000536	0.00077	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	0.000535	0.000768	CbGpPWpGaD
Pranlukast—NFKB1—Corticotropin-releasing hormone—AKT1—ocular cancer	0.000533	0.000766	CbGpPWpGaD
Pranlukast—NFKB1—TNF alpha Signaling Pathway—AKT1—ocular cancer	0.000533	0.000766	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by Interleukins—HRAS—ocular cancer	0.000531	0.000763	CbGpPWpGaD
Pranlukast—NFKB1—Cellular Senescence—CDKN1A—ocular cancer	0.000528	0.000758	CbGpPWpGaD
Pranlukast—NFKB1—DNA Damage Response (only ATM dependent)—HRAS—ocular cancer	0.000528	0.000757	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—GNAQ—ocular cancer	0.000524	0.000752	CbGpPWpGaD
Pranlukast—TNF—Apoptosis—TP53—ocular cancer	0.000518	0.000743	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Breast Cancer Pathway—MYC—ocular cancer	0.000518	0.000743	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	0.000517	0.000743	CbGpPWpGaD
Pranlukast—NFKB1—B Cell Receptor Signaling Pathway—AKT1—ocular cancer	0.000511	0.000734	CbGpPWpGaD
Pranlukast—NFKB1—B Cell Activation—CDKN1A—ocular cancer	0.000509	0.00073	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	0.000492	0.000707	CbGpPWpGaD
Pranlukast—NFKB1—Toll-like Receptor Signaling Pathway—AKT1—ocular cancer	0.000491	0.000705	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—TGFB1—ocular cancer	0.000483	0.000693	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—SAG—ocular cancer	0.000482	0.000692	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—MYC—ocular cancer	0.00048	0.00069	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—TGFB1—ocular cancer	0.000479	0.000688	CbGpPWpGaD
Pranlukast—NFKB1—MAPK Signaling Pathway—MYC—ocular cancer	0.000475	0.000682	CbGpPWpGaD
Pranlukast—NFKB1—MAPK Signaling Pathway—TGFB1—ocular cancer	0.000474	0.000681	CbGpPWpGaD
Pranlukast—NFKB1—Cellular responses to stress—MDM2—ocular cancer	0.000474	0.00068	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—HDAC1—ocular cancer	0.000472	0.000678	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	0.000468	0.000671	CbGpPWpGaD
Pranlukast—NFKB1—DNA Damage Response (only ATM dependent)—AKT1—ocular cancer	0.000466	0.000669	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—MAML2—ocular cancer	0.000464	0.000666	CbGpPWpGaD
Pranlukast—TNF—TNF alpha Signaling Pathway—HRAS—ocular cancer	0.00046	0.000661	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—MDM2—ocular cancer	0.000444	0.000638	CbGpPWpGaD
Pranlukast—TNF—Adipogenesis—TGFB1—ocular cancer	0.000443	0.000637	CbGpPWpGaD
Pranlukast—TNF—SIDS Susceptibility Pathways—EP300—ocular cancer	0.000441	0.000633	CbGpPWpGaD
Pranlukast—TNF—Apoptosis—AKT1—ocular cancer	0.000437	0.000628	CbGpPWpGaD
Pranlukast—TNF—MicroRNAs in cardiomyocyte hypertrophy—AKT1—ocular cancer	0.000437	0.000628	CbGpPWpGaD
Pranlukast—NFKB1—Cellular responses to stress—CDKN1B—ocular cancer	0.000433	0.000621	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	0.000429	0.000616	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	0.000428	0.000614	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	0.000427	0.000613	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—E2F5—ocular cancer	0.000427	0.000613	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Breast Cancer Pathway—TP53—ocular cancer	0.000425	0.00061	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—CDKN2B—ocular cancer	0.000423	0.000608	CbGpPWpGaD
Pranlukast—NFKB1—BDNF signaling pathway—HRAS—ocular cancer	0.000422	0.000606	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—E2F4—ocular cancer	0.000418	0.0006	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—RBL1—ocular cancer	0.00041	0.000589	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	0.000407	0.000585	CbGpPWpGaD
Pranlukast—TNF—TNF alpha Signaling Pathway—AKT1—ocular cancer	0.000406	0.000584	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—CDKN1B—ocular cancer	0.000406	0.000583	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—GNA11—ocular cancer	0.000405	0.000581	CbGpPWpGaD
Pranlukast—NFKB1—Cellular responses to stress—CDKN1A—ocular cancer	0.000399	0.000573	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—TP53—ocular cancer	0.000398	0.000571	CbGpPWpGaD
Pranlukast—CYP3A4—Tryptophan metabolism—MDM2—ocular cancer	0.000395	0.000566	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—TP53—ocular cancer	0.000394	0.000566	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	0.000394	0.000566	CbGpPWpGaD
Pranlukast—NFKB1—MAPK Signaling Pathway—TP53—ocular cancer	0.00039	0.00056	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—E2F1—ocular cancer	0.000389	0.000558	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—CDK4—ocular cancer	0.000387	0.000556	CbGpPWpGaD
Pranlukast—NFKB1—Regulation of toll-like receptor signaling pathway—AKT1—ocular cancer	0.000383	0.000551	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—HRAS—ocular cancer	0.00038	0.000546	CbGpPWpGaD
Pranlukast—NFKB1—Cellular responses to stress—EP300—ocular cancer	0.00038	0.000545	CbGpPWpGaD
Pranlukast—ABCC2—NRF2 pathway—TGFB1—ocular cancer	0.000377	0.000541	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—GNAQ—ocular cancer	0.000376	0.00054	CbGpPWpGaD
Pranlukast—NFKB1—Downstream signaling events of B Cell Receptor (BCR)—HRAS—ocular cancer	0.000375	0.000538	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	0.000375	0.000538	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—CDKN1A—ocular cancer	0.000374	0.000538	CbGpPWpGaD
Pranlukast—TNF—Toll-like Receptor Signaling Pathway—AKT1—ocular cancer	0.000374	0.000537	CbGpPWpGaD
Pranlukast—NFKB1—BDNF signaling pathway—AKT1—ocular cancer	0.000373	0.000535	CbGpPWpGaD
Pranlukast—IL5—Immune System—MDM2—ocular cancer	0.000363	0.000522	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—MYC—ocular cancer	0.000362	0.00052	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—TGFB1—ocular cancer	0.000361	0.000519	CbGpPWpGaD
Pranlukast—NFKB1—Cellular Senescence—TP53—ocular cancer	0.00036	0.000516	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Breast Cancer Pathway—AKT1—ocular cancer	0.000359	0.000515	CbGpPWpGaD
Pranlukast—NFKB1—Fc epsilon receptor (FCERI) signaling—HRAS—ocular cancer	0.000358	0.000514	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—E2F3—ocular cancer	0.000355	0.00051	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	0.000352	0.000506	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—HDAC1—ocular cancer	0.000339	0.000487	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—AKT1—ocular cancer	0.000336	0.000482	CbGpPWpGaD
Pranlukast—IL5—Immune System—CDKN1B—ocular cancer	0.000332	0.000476	CbGpPWpGaD
Pranlukast—NFKB1—B Cell Activation—HRAS—ocular cancer	0.000331	0.000476	CbGpPWpGaD
Pranlukast—NFKB1—Downstream signaling events of B Cell Receptor (BCR)—AKT1—ocular cancer	0.000331	0.000475	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—TFDP1—ocular cancer	0.00033	0.000474	CbGpPWpGaD
Pranlukast—NFKB1—MAPK Signaling Pathway—AKT1—ocular cancer	0.00033	0.000473	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	0.000327	0.000469	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	0.000326	0.000468	CbGpPWpGaD
Pranlukast—TNF—Apoptosis—TP53—ocular cancer	0.000317	0.000455	CbGpPWpGaD
Pranlukast—NFKB1—Fc epsilon receptor (FCERI) signaling—AKT1—ocular cancer	0.000316	0.000454	CbGpPWpGaD
Pranlukast—IL5—Immune System—CDKN1A—ocular cancer	0.000306	0.000439	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—CDKN2B—ocular cancer	0.000304	0.000436	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	0.000297	0.000427	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—TP53—ocular cancer	0.000297	0.000427	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—CDK4—ocular cancer	0.000295	0.000423	CbGpPWpGaD
Pranlukast—NFKB1—B Cell Activation—AKT1—ocular cancer	0.000293	0.00042	CbGpPWpGaD
Pranlukast—TNF—Regulation of toll-like receptor signaling pathway—AKT1—ocular cancer	0.000292	0.000419	CbGpPWpGaD
Pranlukast—IL5—Immune System—EP300—ocular cancer	0.000291	0.000418	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—E2F1—ocular cancer	0.000279	0.0004	CbGpPWpGaD
Pranlukast—NFKB1—Cellular responses to stress—TP53—ocular cancer	0.000272	0.00039	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—PSPH—ocular cancer	0.000272	0.00039	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	0.000268	0.000385	CbGpPWpGaD
Pranlukast—TNF—Apoptosis—AKT1—ocular cancer	0.000268	0.000384	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—MAML2—ocular cancer	0.000263	0.000377	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—MDM2—ocular cancer	0.000253	0.000364	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—AKT1—ocular cancer	0.000251	0.00036	CbGpPWpGaD
Pranlukast—NFKB1—Cytokine Signaling in Immune system—HRAS—ocular cancer	0.000248	0.000356	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—HRAS—ocular cancer	0.000244	0.00035	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—MDM2—ocular cancer	0.000243	0.000349	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—MDM2—ocular cancer	0.000235	0.000337	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—CDKN1B—ocular cancer	0.000231	0.000332	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—EP300—ocular cancer	0.00023	0.00033	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—GNA11—ocular cancer	0.000229	0.000329	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	0.000227	0.000325	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—CDKN1B—ocular cancer	0.000222	0.000319	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—HRAS—ocular cancer	0.000218	0.000313	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—AKT1—ocular cancer	0.000215	0.000309	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—CDKN1B—ocular cancer	0.000214	0.000308	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—CDKN1A—ocular cancer	0.000214	0.000307	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—GNAQ—ocular cancer	0.000213	0.000306	CbGpPWpGaD
Pranlukast—IL5—GPCR downstream signaling—AKT1—ocular cancer	0.000212	0.000305	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—CDKN1A—ocular cancer	0.000205	0.000294	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—CCND1—ocular cancer	0.000205	0.000294	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—EP300—ocular cancer	0.000203	0.000292	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—TGFB1—ocular cancer	0.0002	0.000287	CbGpPWpGaD
Pranlukast—IL5—Immune System—HRAS—ocular cancer	0.000199	0.000286	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—CDKN1A—ocular cancer	0.000198	0.000284	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—AKT1—ocular cancer	0.000193	0.000277	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—HDAC1—ocular cancer	0.000192	0.000276	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—EP300—ocular cancer	0.000188	0.00027	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—PSPH—ocular cancer	0.000179	0.000257	CbGpPWpGaD
Pranlukast—IL5—Immune System—AKT1—ocular cancer	0.000176	0.000253	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—EP300—ocular cancer	0.000175	0.000252	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CDKN2B—ocular cancer	0.000172	0.000247	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—MDM2—ocular cancer	0.000169	0.000242	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—MYC—ocular cancer	0.000164	0.000236	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—TGFB1—ocular cancer	0.000164	0.000235	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—E2F1—ocular cancer	0.000158	0.000227	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—HRAS—ocular cancer	0.000157	0.000226	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—HRAS—ocular cancer	0.000157	0.000225	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—CDKN1B—ocular cancer	0.000154	0.000221	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—TGFB1—ocular cancer	0.000152	0.000219	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—AKT1—ocular cancer	0.000152	0.000219	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—MDM2—ocular cancer	0.000148	0.000212	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—CCND1—ocular cancer	0.000147	0.000211	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—CDKN1A—ocular cancer	0.000142	0.000204	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—HRAS—ocular cancer	0.000139	0.0002	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—AKT1—ocular cancer	0.000139	0.0002	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—AKT1—ocular cancer	0.000138	0.000198	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—EP300—ocular cancer	0.000135	0.000194	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—CDKN1B—ocular cancer	0.000135	0.000194	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—TP53—ocular cancer	0.000135	0.000193	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—HRAS—ocular cancer	0.000134	0.000192	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—HRAS—ocular cancer	0.000129	0.000185	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—CDKN1A—ocular cancer	0.000124	0.000179	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—AKT1—ocular cancer	0.000123	0.000176	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—HRAS—ocular cancer	0.00012	0.000172	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—EP300—ocular cancer	0.000118	0.00017	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—AKT1—ocular cancer	0.000118	0.000169	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—MYC—ocular cancer	0.000118	0.000169	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—TGFB1—ocular cancer	0.000117	0.000169	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—AKT1—ocular cancer	0.000114	0.000163	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—AKT1—ocular cancer	0.000106	0.000152	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—TP53—ocular cancer	9.67e-05	0.000139	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—MDM2—ocular cancer	9.54e-05	0.000137	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—HRAS—ocular cancer	9.25e-05	0.000133	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CDKN1B—ocular cancer	8.71e-05	0.000125	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—GNA11—ocular cancer	8.55e-05	0.000123	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CCND1—ocular cancer	8.31e-05	0.000119	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—AKT1—ocular cancer	8.17e-05	0.000117	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—HRAS—ocular cancer	8.1e-05	0.000116	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CDKN1A—ocular cancer	8.04e-05	0.000115	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—GNAQ—ocular cancer	7.95e-05	0.000114	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—EP300—ocular cancer	7.65e-05	0.00011	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—AKT1—ocular cancer	7.15e-05	0.000103	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—MYC—ocular cancer	6.67e-05	9.57e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—TGFB1—ocular cancer	6.65e-05	9.55e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—EP300—ocular cancer	6.41e-05	9.21e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—GNA11—ocular cancer	5.64e-05	8.09e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—TP53—ocular cancer	5.48e-05	7.86e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—GNAQ—ocular cancer	5.24e-05	7.52e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—HRAS—ocular cancer	5.24e-05	7.52e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—AKT1—ocular cancer	4.62e-05	6.64e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—EP300—ocular cancer	2.86e-05	4.1e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—EP300—ocular cancer	1.88e-05	2.7e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—AKT1—ocular cancer	1.73e-05	2.48e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—AKT1—ocular cancer	1.14e-05	1.63e-05	CbGpPWpGaD
